Forschende haben einen #ME/CFS-Biomarker identifiziert, der eine Sensitivität von 87 % aufweist und zugleich 94 % der gesunden Personen in der Kontrollgruppe korrekt ausschließt.
Sie entdeckten bei #ME/CFS-Patienten spezifische #microRNAs, die bei gesunden Menschen nahezu vollständig fehlen.
Sie entdeckten bei #ME/CFS-Patienten spezifische #microRNAs, die bei gesunden Menschen nahezu vollständig fehlen.
Onderzoekers vinden #MEcvs biomarker met een gevoeligheid van 87% en bij de controle groep werden 94% van de gezonde controles uitgesloten.
Ze vinden specifieke #microRNA's bij #MECFS die bij gezonde mensen bijna niet te vinden zijn.
link.springer.com/article/10.1...
Ze vinden specifieke #microRNA's bij #MECFS die bij gezonde mensen bijna niet te vinden zijn.
link.springer.com/article/10.1...
Circulating extracellular vesicles-microRNAs as potential biomarkers for the identification of ME/CFS: differentiating fatigue-related conditions - Journal of Translational Medicine
Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating, multi-systemic condition that has gained renewed global attention due to its clinical overlap with the growing...
link.springer.com
November 2, 2026 at 11:12 AM
Forschende haben einen #ME/CFS-Biomarker identifiziert, der eine Sensitivität von 87 % aufweist und zugleich 94 % der gesunden Personen in der Kontrollgruppe korrekt ausschließt.
Sie entdeckten bei #ME/CFS-Patienten spezifische #microRNAs, die bei gesunden Menschen nahezu vollständig fehlen.
Sie entdeckten bei #ME/CFS-Patienten spezifische #microRNAs, die bei gesunden Menschen nahezu vollständig fehlen.
Also, I have so many questions about the quest to create autistic monkeys. Captive monkeys have always exhibited tics, repetitive movements, self-harm, & other traits linked to neurodivergence. Why the fixation on a particular biomarker or 2? Are there any critics in this area who know things?
November 2, 2026 at 3:11 PM
Also, I have so many questions about the quest to create autistic monkeys. Captive monkeys have always exhibited tics, repetitive movements, self-harm, & other traits linked to neurodivergence. Why the fixation on a particular biomarker or 2? Are there any critics in this area who know things?
Wer hat meinen Biomarker gesehen? Den hatte ich vorhin hier hingelegt.
November 2, 2026 at 9:51 AM
Wer hat meinen Biomarker gesehen? Den hatte ich vorhin hier hingelegt.
Ich bin mir recht sicher, dass es kurz- bis mittelfristig zielgerichtete Ansätze anhand Subgruppen-spezifischer Biomarker geben wird, die deutlich besser funktionieren werden als unsere aktuellen Primitivmethoden.
October 30, 2026 at 1:23 PM
Ich bin mir recht sicher, dass es kurz- bis mittelfristig zielgerichtete Ansätze anhand Subgruppen-spezifischer Biomarker geben wird, die deutlich besser funktionieren werden als unsere aktuellen Primitivmethoden.
Waters Corp have acquired Mobilion.
I’m interested to see what’s next. A revised cyclic series using SLIM, or two parallel instrument models?
www.biospace.com/press-releas...
I’m interested to see what’s next. A revised cyclic series using SLIM, or two parallel instrument models?
www.biospace.com/press-releas...
Waters Acquires MOBILion Systems, Bringing Advanced Ion-Mobility Separation to its Mass Spectrometry Portfolio with the Speed and Resolution AI Workflows Require for Proteomics Biomarker Discovery
www.biospace.com
November 3, 2026 at 3:17 PM
Waters Corp have acquired Mobilion.
I’m interested to see what’s next. A revised cyclic series using SLIM, or two parallel instrument models?
www.biospace.com/press-releas...
I’m interested to see what’s next. A revised cyclic series using SLIM, or two parallel instrument models?
www.biospace.com/press-releas...
clarify the molecular underpinnings of ME and identify promising avenues for biomarker development and therapeutic intervention.
November 3, 2026 at 2:19 PM
clarify the molecular underpinnings of ME and identify promising avenues for biomarker development and therapeutic intervention.
Treg & Oxidative Stress Biomarker Profiles in #LongCOVID & Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
www.mdpi.com/1422-0067/27...
"Altered T-cell subsets were strongly associated with markers of oxidative (GPX1) and nitrosative (NOS3) stress but not directly with symptom severity”
#mecfs
www.mdpi.com/1422-0067/27...
"Altered T-cell subsets were strongly associated with markers of oxidative (GPX1) and nitrosative (NOS3) stress but not directly with symptom severity”
#mecfs
www.mdpi.com
November 2, 2026 at 12:32 AM
Treg & Oxidative Stress Biomarker Profiles in #LongCOVID & Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
www.mdpi.com/1422-0067/27...
"Altered T-cell subsets were strongly associated with markers of oxidative (GPX1) and nitrosative (NOS3) stress but not directly with symptom severity”
#mecfs
www.mdpi.com/1422-0067/27...
"Altered T-cell subsets were strongly associated with markers of oxidative (GPX1) and nitrosative (NOS3) stress but not directly with symptom severity”
#mecfs
Congratulations to @leoscheller.bsky.social, winner of the #STS Science Award 2026 for his work on „Receptor design for soluble biomarker-responsive CAR-T cells“. @leibnizlib.bsky.social
November 4, 2026 at 11:46 AM
Congratulations to @leoscheller.bsky.social, winner of the #STS Science Award 2026 for his work on „Receptor design for soluble biomarker-responsive CAR-T cells“. @leibnizlib.bsky.social
2/1 Können PBMC-EV-Metriken als diagnostische, therapeutische und phänotypische Biomarker dienen?
October 29, 2026 at 11:38 AM
2/1 Können PBMC-EV-Metriken als diagnostische, therapeutische und phänotypische Biomarker dienen?
Why cancer biomarker testing is personal for Mark-Paul Gosselaar
Biomarker testing improves your chance of receiving a targeted therapy by 15‑30% and can cut time to effective treatment by up to three weeks. Request t...
https://gworky.com/article/why-cancer-biomarker-testing-is-personal
Biomarker testing improves your chance of receiving a targeted therapy by 15‑30% and can cut time to effective treatment by up to three weeks. Request t...
https://gworky.com/article/why-cancer-biomarker-testing-is-personal
Why cancer biomarker testing is personal for Mark-Paul Gosselaar
Research-backed guide on Groundwork.
gworky.com
November 3, 2026 at 2:00 PM
Why cancer biomarker testing is personal for Mark-Paul Gosselaar
Biomarker testing improves your chance of receiving a targeted therapy by 15‑30% and can cut time to effective treatment by up to three weeks. Request t...
https://gworky.com/article/why-cancer-biomarker-testing-is-personal
Biomarker testing improves your chance of receiving a targeted therapy by 15‑30% and can cut time to effective treatment by up to three weeks. Request t...
https://gworky.com/article/why-cancer-biomarker-testing-is-personal
Individualized reference values for NT-proBNP in chronic heart failure: A Bayesian method to enhance biomarker-based patient monitoring. Spin-off from monitoring of elite athletes🏅➡️❤️🩹. Full paper to come soon. academic.oup.com/eurheartj/ar... @i-med.ac.at @uniinnsbruck.bsky.social @uni-saarland.de
November 2, 2026 at 4:23 PM
Individualized reference values for NT-proBNP in chronic heart failure: A Bayesian method to enhance biomarker-based patient monitoring. Spin-off from monitoring of elite athletes🏅➡️❤️🩹. Full paper to come soon. academic.oup.com/eurheartj/ar... @i-med.ac.at @uniinnsbruck.bsky.social @uni-saarland.de
From Brazil 🇧🇷
Multifactorial biomarker profiles in fatigued and non-fatigued post-COVID-19 patients: insights from a one-year follow-up
Screenshot from latest Science for ME weekly update
#LongCovid #PASC #PwLC #postcovid #postcovid19 #PostCovidSyndrome
1/
Multifactorial biomarker profiles in fatigued and non-fatigued post-COVID-19 patients: insights from a one-year follow-up
Screenshot from latest Science for ME weekly update
#LongCovid #PASC #PwLC #postcovid #postcovid19 #PostCovidSyndrome
1/
November 5, 2026 at 1:27 AM
From Brazil 🇧🇷
Multifactorial biomarker profiles in fatigued and non-fatigued post-COVID-19 patients: insights from a one-year follow-up
Screenshot from latest Science for ME weekly update
#LongCovid #PASC #PwLC #postcovid #postcovid19 #PostCovidSyndrome
1/
Multifactorial biomarker profiles in fatigued and non-fatigued post-COVID-19 patients: insights from a one-year follow-up
Screenshot from latest Science for ME weekly update
#LongCovid #PASC #PwLC #postcovid #postcovid19 #PostCovidSyndrome
1/
👵👴Early Homo sapiens in South Africa experienced contrasting, non‑analogous environments shaped by shifting hydrology and vegetation.
👉Read more here: www.nature.com/articles/s43...
👉Read more here: www.nature.com/articles/s43...
Non-analog environments supported early Homo sapiens in southern Africa 200 000 years ago - Communications Earth & Environment
Early Homo sapiens in South Africa experienced contrasting, non‑analogous environments shaped by shifting hydrology and vegetation, based on plant biomarker isotope records and revised dating of Middl...
www.nature.com
November 3, 2026 at 2:39 PM
👵👴Early Homo sapiens in South Africa experienced contrasting, non‑analogous environments shaped by shifting hydrology and vegetation.
👉Read more here: www.nature.com/articles/s43...
👉Read more here: www.nature.com/articles/s43...
Treg and Oxidative Stress Biomarker Profiles in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome — Todorova et al
"Altered T-cell subsets were strongly associated with markers of oxidative (GPX1) and nitrosative (NOS3) stress but not directly with symptom severity."
#MECFS
"Altered T-cell subsets were strongly associated with markers of oxidative (GPX1) and nitrosative (NOS3) stress but not directly with symptom severity."
#MECFS
Article Link
www.mdpi.com
November 2, 2026 at 9:46 AM
Treg and Oxidative Stress Biomarker Profiles in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome — Todorova et al
"Altered T-cell subsets were strongly associated with markers of oxidative (GPX1) and nitrosative (NOS3) stress but not directly with symptom severity."
#MECFS
"Altered T-cell subsets were strongly associated with markers of oxidative (GPX1) and nitrosative (NOS3) stress but not directly with symptom severity."
#MECFS
Could STEAP4⁺ neutrophils signal #LungMetastasis?
Their circulating levels distinguished #BreastCancer patients with lung metastases from those with localized tumors, suggesting #biomarker potential. @pku1898.bsky.social
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
Their circulating levels distinguished #BreastCancer patients with lung metastases from those with localized tumors, suggesting #biomarker potential. @pku1898.bsky.social
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
November 3, 2026 at 12:00 PM
Could STEAP4⁺ neutrophils signal #LungMetastasis?
Their circulating levels distinguished #BreastCancer patients with lung metastases from those with localized tumors, suggesting #biomarker potential. @pku1898.bsky.social
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
Their circulating levels distinguished #BreastCancer patients with lung metastases from those with localized tumors, suggesting #biomarker potential. @pku1898.bsky.social
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
It avoids:
- biopsy infection risk
- ADT toxicity
It maintains PSA biomarker test reliability throughout as the most sensitive, accurate and reliable measure of prostate cancer burden. Best tracker than any other.
- biopsy infection risk
- ADT toxicity
It maintains PSA biomarker test reliability throughout as the most sensitive, accurate and reliable measure of prostate cancer burden. Best tracker than any other.
November 4, 2026 at 11:44 AM
It avoids:
- biopsy infection risk
- ADT toxicity
It maintains PSA biomarker test reliability throughout as the most sensitive, accurate and reliable measure of prostate cancer burden. Best tracker than any other.
- biopsy infection risk
- ADT toxicity
It maintains PSA biomarker test reliability throughout as the most sensitive, accurate and reliable measure of prostate cancer burden. Best tracker than any other.
New Study: Biological aging is decreased by hormone replacement therapy (but only if your blood sugar is imbalanced)
HRT use also correlated with decreased mortality.
Take-away: More evidence that HRT may be a good idea🧪👩🔬
link.springer.com/article/10.1...
HRT use also correlated with decreased mortality.
Take-away: More evidence that HRT may be a good idea🧪👩🔬
link.springer.com/article/10.1...
Hormone replacement therapy through the lens of epigenetic clock: estrogen signals, glycemic status, and lifespan - Biology of Sex Differences
Background Epigenetic age acceleration (EAA) is a critical biomarker of aging. Hormone replacement therapy (HRT) is commonly used to alleviate age-related diseases, while glycemic status also influenc...
link.springer.com
November 2, 2026 at 2:18 AM
New Study: Biological aging is decreased by hormone replacement therapy (but only if your blood sugar is imbalanced)
HRT use also correlated with decreased mortality.
Take-away: More evidence that HRT may be a good idea🧪👩🔬
link.springer.com/article/10.1...
HRT use also correlated with decreased mortality.
Take-away: More evidence that HRT may be a good idea🧪👩🔬
link.springer.com/article/10.1...
Biomarker data support separating moderate from severe diabetic foot infection. diabeticfootonline.c...
November 3, 2026 at 12:17 PM
Biomarker data support separating moderate from severe diabetic foot infection. diabeticfootonline.c...
#ASNCJASN study: Can a urine biomarker identify AKI patients before they reach a tipping point? In ICU patients, higher urinary #CCL14 levels signaled a markedly greater risk of persistent severe AKI and kidney replacement therapy. kidney.pub/CJASN1212
November 2, 2026 at 4:30 PM
#ASNCJASN study: Can a urine biomarker identify AKI patients before they reach a tipping point? In ICU patients, higher urinary #CCL14 levels signaled a markedly greater risk of persistent severe AKI and kidney replacement therapy. kidney.pub/CJASN1212
New paper alert - and its a big one 📢
We combined a biomarker record of the complete sequence at Florisbad with new luminescence ages for the famous hominin skull. We show how Homo sapiens lived in non-analogue environments 200 000 years ago in South Africa doi.org/10.1038/s432... 🦣🏺#openaccess
We combined a biomarker record of the complete sequence at Florisbad with new luminescence ages for the famous hominin skull. We show how Homo sapiens lived in non-analogue environments 200 000 years ago in South Africa doi.org/10.1038/s432... 🦣🏺#openaccess
Non-analog environments supported early Homo sapiens in southern Africa 200 000 years ago - Communications Earth & Environment
Early Homo sapiens in South Africa experienced contrasting, non‑analogous environments shaped by shifting hydrology and vegetation, based on plant biomarker isotope records and revised dating of Middl...
doi.org
October 30, 2026 at 11:11 AM
New paper alert - and its a big one 📢
We combined a biomarker record of the complete sequence at Florisbad with new luminescence ages for the famous hominin skull. We show how Homo sapiens lived in non-analogue environments 200 000 years ago in South Africa doi.org/10.1038/s432... 🦣🏺#openaccess
We combined a biomarker record of the complete sequence at Florisbad with new luminescence ages for the famous hominin skull. We show how Homo sapiens lived in non-analogue environments 200 000 years ago in South Africa doi.org/10.1038/s432... 🦣🏺#openaccess
BioVie will be sharing new Long COVID biomarker data at the International LC Conference this month!
investors.bioviepharma.com/news/news-de...
1/
investors.bioviepharma.com/news/news-de...
1/
4th Long COVID International Conference 2026
Hybrid event focusing on Long COVID, COVID-19, Long COVID. 2026-11-12 to 2026-11-13 in Nice
academicmedicaleducation.com
November 3, 2026 at 2:55 PM
BioVie will be sharing new Long COVID biomarker data at the International LC Conference this month!
investors.bioviepharma.com/news/news-de...
1/
investors.bioviepharma.com/news/news-de...
1/
Who really benefits from chemotherapy after colorectal cancer surgery? DoMore Diagnostics’ AI biomarker analyses existing tumour slides. In 900+ ctDNA-negative patients, Histotype Px identified around two-thirds of recurrences missed by ctDNA testing. #healthcare
AI biomarker could improve colorectal cancer treatment | ICT&health
An AI-based biomarker could help oncologists determine which colorectal cancer patients are likely to benefit from chemotherapy after surgery.
www.icthealth.org
November 3, 2026 at 4:03 PM
Who really benefits from chemotherapy after colorectal cancer surgery? DoMore Diagnostics’ AI biomarker analyses existing tumour slides. In 900+ ctDNA-negative patients, Histotype Px identified around two-thirds of recurrences missed by ctDNA testing. #healthcare
$WAT 🤝
Waters Corporation acquired MOBILion Systems, adding advanced ion-mobility separation technology to its mass spectrometry portfolio for proteomics biomarker discovery.
Timely market event
More market highlights:
https://rayvio.app/dashboard/?utm_source=lifatpt
Waters Corporation acquired MOBILion Systems, adding advanced ion-mobility separation technology to its mass spectrometry portfolio for proteomics biomarker discovery.
Timely market event
More market highlights:
https://rayvio.app/dashboard/?utm_source=lifatpt
November 3, 2026 at 10:55 AM
$WAT 🤝
Waters Corporation acquired MOBILion Systems, adding advanced ion-mobility separation technology to its mass spectrometry portfolio for proteomics biomarker discovery.
Timely market event
More market highlights:
https://rayvio.app/dashboard/?utm_source=lifatpt
Waters Corporation acquired MOBILion Systems, adding advanced ion-mobility separation technology to its mass spectrometry portfolio for proteomics biomarker discovery.
Timely market event
More market highlights:
https://rayvio.app/dashboard/?utm_source=lifatpt
Trial Tuesday! Alliance A071401 led by Dr. Priscilla Brastianos of Mass General is enrolling patients with progressive meningioma. This study evaluates biomarker-driven targeted agents based on specific genetic mutations. Full protocol at 👇 🔗 https://bit.ly/A071401-trial
November 3, 2026 at 11:00 AM
Trial Tuesday! Alliance A071401 led by Dr. Priscilla Brastianos of Mass General is enrolling patients with progressive meningioma. This study evaluates biomarker-driven targeted agents based on specific genetic mutations. Full protocol at 👇 🔗 https://bit.ly/A071401-trial